https://orcid.org/0000-0003-2017-3526
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Angelo Armandi, Maurice Michel, Kamela Gjini, Tilman Emrich, Elisabetta Bugianesi & Jorn M. Schattenberg. (2023) Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease. Expert Review of Molecular Diagnostics 23:9, pages 771-782.
Read now
Read now
Ying Liu, Zhifang Zhong, Zhihong Li, Xin Li, Shengkun Zhang, Jie Sun, Jingfang Zhai, Xuekui Liu & Min Liu. (2022) Association Between NLR and NAFLD in Adults Exposed to Famine in Early Life. Risk Management and Healthcare Policy 15, pages 1561-1568.
Read now
Read now
Articles from other publishers (19)
Na Wu, Jie Li, Jing Zhang, Fan Yuan, Ning Yu, Fengwei Zhang, Dong Li, Jianying Wang, Lei Zhang, Yi Shi, Guang He, Guang Ji & Baocheng Liu. (2023) Waist circumference mediates the association between rs1260326 in GCKR gene and the odds of lean NAFLD. Scientific Reports 13:1.
Crossref
Crossref
Zhaoping Wu, Ting Ouyang, Hechun Liu, Lingling Cao & Weili Chen. (2023) Perfluoroalkyl substance (PFAS) exposure and risk of nonalcoholic fatty liver disease in the elderly: results from NHANES 2003–2014. Environmental Science and Pollution Research 30:23, pages 64342-64351.
Crossref
Crossref
Dayana Cabrera, Jorge Moncayo-Rizzo, Karen Cevallos & Geovanny Alvarado-Villa. (2023) Waist Circumference as a Risk Factor for Non-Alcoholic Fatty Liver Disease in Older Adults in Guayaquil, Ecuador. Geriatrics 8:2, pages 42.
Crossref
Crossref
Caie Wang, Ghid Kanaan, Yiyang Shang, Lu Chai, Hui Li & Xingshun Qi. (2023) Silymarin for treatment of adults with nonalcoholic fatty liver disease. Cochrane Database of Systematic Reviews 2023:4.
Crossref
Crossref
Shuwei Weng, Die Hu, Jin Chen, Yanyi Yang & Daoquan Peng. (2023) Prediction of Fatty Liver Disease in a Chinese Population Using Machine-Learning Algorithms. Diagnostics 13:6, pages 1168.
Crossref
Crossref
Ruirui Ren & Yang Zheng. (2023) Sex differences in cardiovascular and all-cause mortality in nonalcoholic fatty liver disease in the US population. Nutrition, Metabolism and Cardiovascular Diseases.
Crossref
Crossref
Yongyuan He, Yinghong Su, Chengcheng Duan, Siyuan Wang, Wei He, Yingting Zhang, Xiaofei An & Ming He. (2023) Emerging role of aging in the progression of NAFLD to HCC. Ageing Research Reviews 84, pages 101833.
Crossref
Crossref
Maurice Michel, Alisha Wahl, Malena Anders, Saleh A. Alqahtani, Wolfgang M. Kremer, Peter R. Galle, Christian Labenz, Daniel Grimm, Martin Sprinzl & Jörn M. Schattenberg. (2022) Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV. Quality of Life Research 32:2, pages 401-411.
Crossref
Crossref
Camille M. Selvais, María A. Davis‐López de Carrizosa, Maxime Nachit, Romain Versele, Nicolas Dubuisson, Laurence Noel, Justine Gillard, Isabelle A. Leclercq, Sonia M. Brichard & Michel Abou‐Samra. (2022) AdipoRon enhances healthspan in middle‐aged obese mice: striking alleviation of myosteatosis and muscle degenerative markers. Journal of Cachexia, Sarcopenia and Muscle 14:1, pages 464-478.
Crossref
Crossref
Mohammad Sadiq Jeeyavudeen, Shahanas KA Khan, Sherouk Fouda & Joseph M Pappachan. (2023) Management of metabolic-associated fatty liver disease: The diabetology perspective. World Journal of Gastroenterology 29:1, pages 126-143.
Crossref
Crossref
Jun Guo, Xiuqing Huang, Lin Dou, Mingjing Yan, Tao Shen, Weiqing Tang & Jian Li. (2022) Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Wen-Pei Chang & Yu-Pei Chang. (2022) Correlation between Component Factors of Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Nurses: An Observational and Cross-Sectional Study. International Journal of Environmental Research and Public Health 19:23, pages 16294.
Crossref
Crossref
Michelle Berenice Vega Joubert, Valentina Degrave, Paola Ingaramo, María Eugenia Oliva & María Eugenia D'Alessandro. (2022)
Salvia hispanica
L. (chia) seed improves liver inflammation and endothelial dysfunction in an experimental model of metabolic syndrome
. Food & Function 13:21, pages 11249-11261.
Crossref
Crossref
Ritesh K. Baboota, Rosa Spinelli, Malin C. Erlandsson, Bruna B. Brandao, Marsel Lino, Hong Yang, Adil Mardinoglu, Maria I. Bokarewa, Jeremie Boucher, C. Ronald Kahn & Ulf Smith. (2022) Chronic hyperinsulinemia promotes human hepatocyte senescence. Molecular Metabolism 64, pages 101558.
Crossref
Crossref
Risha Catra Pradhany, Ferbian Milas Siswanto, Hendro Sukoco, I Nyoman Suarsana & I Gusti Ayu Agung Suartini. (2022) L-carnitine Prevents Hepatic Steatosis in Deep-Frying Oil-Treated Rat. Biomedical and Pharmacology Journal 15:3, pages 1751-1758.
Crossref
Crossref
Lucrezia Irene Maria Campagnoli, Nicoletta Marchesi, Mariapia Vairetti, Alessia Pascale, Andrea Ferrigno & Annalisa Barbieri. (2022) Age-Related NAFLD: The Use of Probiotics as a Supportive Therapeutic Intervention. Cells 11:18, pages 2827.
Crossref
Crossref
Gonzalo Jorquera & Francisco Javier Cubero. (2022) Inflammaging, a Common Factor in the Development of Sarcopenia and Metabolic-Associated Liver Disease (MAFLD). Livers 2:3, pages 116-118.
Crossref
Crossref
Ryosuke Yamane, Kentaro Yoshioka, Kazuhiko Hayashi, Yuko Shimizu, Yuki Ito, Komei Matsushita, Michiyo Yoshizaki, Go Kajikawa, Taro Mizutani, Atsuko Watarai, Kosuke Tachi & Hidemi Goto. (2022) Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus. World Journal of Hepatology 14:6, pages 1226-1234.
Crossref
Crossref
GABRIELA LÓPEZ-ALMADA, J. ABRAHAM DOMÍNGUEZ-AVILA, GUSTAVO A. GONZÁLEZ-AGUILAR, MARIA ESTHER MEJÍA-LEÓN & NORMA JULIETA SALAZAR-LÓPEZ. (2022) ABORDAJE PREVENTIVO EN LA ENFERMEDAD POR HÍGADO GRASO NO ALCOHÓLICO. EPISTEMUS 16:32.
Crossref
Crossref